SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-047733
Filing Date
2023-04-20
Accepted
2023-04-20 16:02:46
Documents
19

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm232007d5_def14a.htm   iXBRL DEF 14A 969154
6 GRAPHIC sg_jillcmilne-bw.jpg GRAPHIC 21348
7 GRAPHIC bc_capandtsr-4c.jpg GRAPHIC 217549
8 GRAPHIC bc_capandnetincome-4c.jpg GRAPHIC 252234
9 GRAPHIC px_page01-bw.jpg GRAPHIC 1161231
10 GRAPHIC px_page02-bw.jpg GRAPHIC 1431511
  Complete submission text file 0001104659-23-047733.txt   9260801

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20221231.xsd EX-101.SCH 7547
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxs-20221231_def.xml EX-101.DEF 5592
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20221231_lab.xml EX-101.LAB 13545
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20221231_pre.xml EX-101.PRE 4773
13 EXTRACTED XBRL INSTANCE DOCUMENT tm232007d5_def14a_htm.xml XML 127380
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 23833100
SIC: 2834 Pharmaceutical Preparations